ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill

NCT01317381 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2011-03-17

No results posted yet for this study

Summary

ICG- Leberfunktionstest versus "neue" Biomarker als prognostischer Marker bei intensivmedizischen Patienten

Conditions

  • Critically Ill Patients

Interventions

PROCEDURE

Observational

Blood draw

Sponsors & Collaborators

  • Intuitive Surgical

    collaborator INDUSTRY
  • University of Zurich

    lead OTHER

Principal Investigators

  • 01 Studienregister MasterAdmins · UniversitaetsSpital Zuerich

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Completion
2011-05-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01317381 on ClinicalTrials.gov